US Patent Issued to Ionis Pharmaceuticals on Sept. 29 for "Synthesis of oligomeric compounds comprising phosphorothioate diester and phosphodiester linkages" (California Inventors)

Posted On: 2026-09-30

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,260, issued on Sept. 29, was assigned to Ionis Pharmaceuticals Inc. (Carlsbad, Calif.). "Synthesis of oligomeric compounds comprising phos... Read More

US Patent Issued to Uniwersytet Warszawski, Explorna Therapeutics Sp. z on Sept. 29 for "MRNA 5'-end cap analogs modified within phosphate residues, RNA molecule incorporating the same, uses thereof and method of synthesizing RNA molecule or peptide" (Polish Inventors)

Posted On: 2026-09-30

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,261, issued on Sept. 29, was assigned to Uniwersytet Warszawski (Warsaw, Poland) and Explorna Therapeutics Sp. z o.o. (Warsaw, Poland). "M... Read More

US Patent Issued to FUJIMOTO CHEMICALS on Sept. 29 for "Alkoxyphenyl derivatives, protected nucleosides and protected nucleotides, method for producing oligonucleotides, and method for removing substituents" (Japanese Inventors)

Posted On: 2026-09-30

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,262, issued on Sept. 29, was assigned to FUJIMOTO CHEMICALS Co. LTD. (Osaka, Japan). "Alkoxyphenyl derivatives, protected nucleosides and ... Read More

US Patent Issued to Evestra on Sept. 29 for "Orally active leukemia inhibitory factor (LIF) antagonists for the treatment of cancer" (Texas Inventors)

Posted On: 2026-09-30

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,263, issued on Sept. 29, was assigned to Evestra Inc. (Schertz, Texas). "Orally active leukemia inhibitory factor (LIF) antagonists for th... Read More

US Patent Issued to OncoTherapy Science on Sept. 29 for "FOXM1-derived peptide, and vaccine including same" (Japanese Inventors)

Posted On: 2026-09-30

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,265, issued on Sept. 29, was assigned to OncoTherapy Science Inc. (Kawasaki, Japan). "FOXM1-derived peptide, and vaccine including same" w... Read More

US Patent Issued to CELLICON LAB on Sept. 29 for "Antimicrobial peptide with excellent microbial cytoplasm elution effect" (South Korean Inventors)

Posted On: 2026-09-30

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,266, issued on Sept. 29, was assigned to CELLICON LAB INC. (Daejeon, South Korea). "Antimicrobial peptide with excellent microbial cytopla... Read More

US Patent Issued to Sichuan Gooddoctor Panxi Pharmaceutical on Sept. 29 for "Polypeptide compound and use thereof in treatment of enteritis" (Chinese Inventor)

Posted On: 2026-09-30

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,267, issued on Sept. 29, was assigned to Sichuan Gooddoctor Panxi Pharmaceutical Co. Ltd. (Xichang City, China). "Polypeptide compound and... Read More

US Patent Issued to KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY on Sept. 29 for "High-potency SARS coronavirus 2 antigen and vaccine composition comprising same" (South Korean Inventors)

Posted On: 2026-09-30

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,268, issued on Sept. 29, was assigned to KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (Daejeon, South Korea). "High-potency SARS corona... Read More

US Patent Issued to The Brigham and Women's Hospital on Sept. 29 for "Methods and compositions for delivery of agents across the blood-brain barrier" (Massachusetts Inventor)

Posted On: 2026-09-30

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,269, issued on Sept. 29, was assigned to The Brigham and Women's Hospital Inc. (Boston). "Methods and compositions for delivery of agents ... Read More

US Patent Issued to TWILIGHT BIOSCIENCE on Sept. 29 for "HERV-K (HML-2) Env analog fusion proteins for antigen specific immunotherapy and methods of use" (Maryland, Massachusetts Inventors)

Posted On: 2026-09-30

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,270, issued on Sept. 29, was assigned to TWILIGHT BIOSCIENCE INC. (Topsfield, Mass.). "HERV-K (HML-2) Env analog fusion proteins for antig... Read More

Exclusive

Category

Source

Publication

Byline

Location

US Patent Issued to Ionis Pharmaceuticals on Sept. 29 for "Synthesis of oligomeric compounds comprising phosphorothioate diester and phosphodiester linkages" (California Inventors)

US Patent Issued to Uniwersytet Warszawski, Explorna Therapeutics Sp. z on Sept. 29 for "MRNA 5'-end cap analogs modified within phosphate residues, RNA molecule incorporating the same, uses thereof and method of synthesizing RNA molecule or peptide" (Polish Inventors)

US Patent Issued to FUJIMOTO CHEMICALS on Sept. 29 for "Alkoxyphenyl derivatives, protected nucleosides and protected nucleotides, method for producing oligonucleotides, and method for removing substituents" (Japanese Inventors)

US Patent Issued to Evestra on Sept. 29 for "Orally active leukemia inhibitory factor (LIF) antagonists for the treatment of cancer" (Texas Inventors)

US Patent Issued to OncoTherapy Science on Sept. 29 for "FOXM1-derived peptide, and vaccine including same" (Japanese Inventors)

US Patent Issued to CELLICON LAB on Sept. 29 for "Antimicrobial peptide with excellent microbial cytoplasm elution effect" (South Korean Inventors)

US Patent Issued to Sichuan Gooddoctor Panxi Pharmaceutical on Sept. 29 for "Polypeptide compound and use thereof in treatment of enteritis" (Chinese Inventor)

US Patent Issued to KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY on Sept. 29 for "High-potency SARS coronavirus 2 antigen and vaccine composition comprising same" (South Korean Inventors)

US Patent Issued to The Brigham and Women's Hospital on Sept. 29 for "Methods and compositions for delivery of agents across the blood-brain barrier" (Massachusetts Inventor)

US Patent Issued to TWILIGHT BIOSCIENCE on Sept. 29 for "HERV-K (HML-2) Env analog fusion proteins for antigen specific immunotherapy and methods of use" (Maryland, Massachusetts Inventors)